Chemed (NYSE:CHE) Issues FY 2026 Earnings Guidance

Key Points

• Chemed set FY 2026 EPS guidance of 24.00–24.75, above the consensus estimate of 23.48.
• The company reported quarterly EPS of $5.65 (vs. $5.39 expected) while revenue of $657.5M slightly missed estimates, and the stock traded up about 2.8% to $383.42 on the news.
• Several analysts have cut ratings and price targets recently (including RBC, Oppenheimer, Jefferies and Weiss), leaving a consensus rating of Hold and a $498 average target.

Chemed (NYSE:CHE - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 24.000-24.75 for the period, compared to the consensus EPS estimate of 23.480. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Royal Bank Of Canada restated a "sector perform" rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Zacks Research cut shares of Chemed from a "hold" rating to a "strong sell" rating in a research report on Wednesday, March 4th. Weiss Ratings cut shares of Chemed from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Monday, April 13th. Oppenheimer decreased their price objective on shares of Chemed from $580.00 to $500.00 and set an "outperform" rating for the company in a research report on Friday, February 27th. Finally, Jefferies Financial Group cut shares of Chemed from a "buy" rating to a "hold" rating in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $498.00.

Chemed Trading Up 2.8%

NYSE CHE traded up $10.27 on Thursday, hitting $383.42. 257,430 shares of the company were exchanged, compared to its average volume of 227,753. The company has a market cap of $5.60 billion, a PE ratio of 20.87, a PEG ratio of 1.48 and a beta of 0.49. Chemed has a 12 month low of $365.20 and a 12 month high of $583.96. The stock has a fifty day moving average of $405.82 and a 200-day moving average of $426.70.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.39 by $0.26. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, analysts expect that Chemed will post 21.92 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed's dividend payout ratio (DPR) is 13.06%.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the transaction, the chief executive officer directly owned 93,719 shares of the company's stock, valued at approximately $37,785,626.42. This trade represents a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.29% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Commonwealth Equity Services LLC lifted its position in shares of Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company's stock valued at $314,000 after purchasing an additional 22 shares in the last quarter. Cim LLC increased its holdings in Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company's stock worth $958,000 after buying an additional 24 shares during the last quarter. Merit Financial Group LLC increased its holdings in Chemed by 4.0% during the third quarter. Merit Financial Group LLC now owns 940 shares of the company's stock worth $421,000 after buying an additional 36 shares during the last quarter. Deutsche Bank AG increased its holdings in Chemed by 1.2% during the fourth quarter. Deutsche Bank AG now owns 2,929 shares of the company's stock worth $1,253,000 after buying an additional 36 shares during the last quarter. Finally, Public Employees Retirement System of Ohio increased its holdings in Chemed by 0.8% during the third quarter. Public Employees Retirement System of Ohio now owns 5,007 shares of the company's stock worth $2,242,000 after buying an additional 40 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.